Literature DB >> 1937804

Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells.

F J Gomez1, A M Gomez, G S Deepe.   

Abstract

We reported previously that a detergent extract of the cell wall and cell membrane of Histoplasma capsulatum yeast cells contains antigens recognized by T cells. In T-cell immunoblot analysis, a region encompassing 62 kDa was stimulatory for an H. capsulatum-reactive T-cell line and T-cell clones derived from C57BL/6 mice. In this study, we isolated a 62-kDa band, termed HIS-62, from electrophoresed cell wall and cell membrane of H. capsulatum yeast cells and examined its antigenicity and immunogenicity. C57BL/6, BALB/c, and CBA/J mice that were immunized with viable H. capsulatum yeast cells mounted a delayed-type hypersensitivity response to HIS-62 that was stronger than that of normal controls. Spleen cells from each strain of mouse immunized with viable yeast cells proliferated vigorously in response to HIS-62; conversely, splenocytes from control animals did not recognize this antigen. A T-cell line and 5 of 5 T-cell clones from C57BL/6 mice, 10 of 15 BALB/c T-cell hybridomas, and 8 of 12 CBA/J T-cell hybridomas recognized HIS-62. A cutaneous delayed-type hypersensitivity response to the antigen was apparent in each strain of mouse that was injected with 80 micrograms of HIS-62 mixed with Freund adjuvant. In addition, spleen cells from HIS-62-immunized mice proliferated in vitro in response to this antigen. Vaccination of each strain of mouse with 80 micrograms of HIS-62 conferred protection against a lethal intravenous challenge with H. capsulatum yeast cells. Thus, HIS-62 appears to be an important target of the cellular immune response to H. capsulatum and induces a protective immune response in mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937804      PMCID: PMC259063          DOI: 10.1128/iai.59.12.4459-4464.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Survival of Histoplasma capsulatum in experimental histoplasmosis in mice.

Authors:  S SASLAW; J SCHAEFER
Journal:  Proc Soc Exp Biol Med       Date:  1956-03

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Significance of thymus-derived lymphocytes in immunity elicited by immunization with ribosomes or live yeast cells of Histoplasma capsulatum.

Authors:  R P Tewari; D K Sharma; A Mathur
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

5.  Demonstration of species-specific and cross-reactive components of the adult microsomal antigens from Schistosoma mansoni and S. japonicum (MAMA and JAMA).

Authors:  V C Tsang; K Hancock; S E Maddison; A L Beatty; D M Moss
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

6.  Removal of sodium dodecyl sulfate from proteins by ion-pair extraction.

Authors:  W H Konigsberg; L Henderson
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis.

Authors:  M W Hunkapiller; E Lujan; F Ostrander; L E Hood
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

8.  Inhibition of growth of Histoplasma capsulatum by lymphokine-stimulated macrophages.

Authors:  B Wu-Hsieh; D H Howard
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

9.  Cellular mediators of anti-histoplasma immunity: I. Protective immunity and cellular changes in spleens of mice immunized by sublethal infection with yeast cells of histoplasma capsulatum.

Authors:  N Khardori; L von Behren; S Chaudhary; P McConnachie; A Strano; R P Tewari
Journal:  Mykosen       Date:  1986-03

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  26 in total

1.  Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum.

Authors:  Holly L Allen; George S Deepe
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

2.  Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance.

Authors:  M Wüthrich; H I Filutowicz; B S Klein
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

3.  Discovery of a role for Hsp82 in Histoplasma virulence through a quantitative screen for macrophage lethality.

Authors:  Jessica A Edwards; Olga Zemska; Chad A Rappleye
Journal:  Infect Immun       Date:  2011-05-23       Impact factor: 3.441

4.  Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis.

Authors:  G S Deepe; R Gibbons
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens.

Authors:  R A Bryan; A J Guimaraes; S Hopcraft; Z Jiang; K Bonilla; A Morgenstern; F Bruchertseifer; M Del Poeta; A Torosantucci; A Cassone; J D Nosanchuk; A Casadevall; E Dadachova
Journal:  Mycopathologia       Date:  2011-11-03       Impact factor: 2.574

6.  Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum.

Authors:  Allan J Guimarães; Susana Frases; Francisco J Gomez; Rosely M Zancopé-Oliveira; Joshua D Nosanchuk
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

7.  Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice.

Authors:  George S Deepe; William R Buesing; Gary R Ostroff; Ambily Abraham; Charles A Specht; Haibin Huang; Stuart M Levitz
Journal:  Vaccine       Date:  2018-05-02       Impact factor: 3.641

8.  Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis.

Authors:  F J Gomez; J A Cain; R Gibbons; R Allendoerfer; G S Deepe
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

Review 9.  Heat Shock Proteins in Histoplasma and Paracoccidioides.

Authors:  Levi G Cleare; Daniel Zamith-Miranda; Joshua D Nosanchuk
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

10.  Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis.

Authors:  S L Newman; L Gootee; G Brunner; G S Deepe
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.